Compare ORN & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ORN | CYRX |
|---|---|---|
| Founded | 1994 | 1999 |
| Country | United States | United States |
| Employees | N/A | 1100 |
| Industry | Military/Government/Technical | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 411.7M | 419.3M |
| IPO Year | 2007 | 2008 |
| Metric | ORN | CYRX |
|---|---|---|
| Price | $11.57 | $10.08 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 9 |
| Target Price | ★ $16.25 | $12.94 |
| AVG Volume (30 Days) | 258.2K | ★ 399.7K |
| Earning Date | 04-28-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 220.00 | 156.22 |
| EPS | 0.06 | ★ 1.40 |
| Revenue | ★ $852,260,000.00 | $176,177,000.00 |
| Revenue This Year | $8.50 | $11.06 |
| Revenue Next Year | $7.83 | $8.45 |
| P/E Ratio | $195.33 | ★ $7.19 |
| Revenue Growth | ★ 7.01 | N/A |
| 52 Week Low | $5.68 | $5.21 |
| 52 Week High | $15.00 | $11.45 |
| Indicator | ORN | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 50.83 | 72.51 |
| Support Level | $9.85 | $9.18 |
| Resistance Level | $11.85 | $10.23 |
| Average True Range (ATR) | 0.46 | 0.41 |
| MACD | 0.13 | 0.18 |
| Stochastic Oscillator | 63.64 | 94.55 |
Orion Group Holdings Inc is a specialty construction company serving the infrastructure, industrial, and building sectors, providing services both on and off the water in the continental United States, Alaska, Canada, and the Caribbean Basin through its marine segment and its concrete segment. Its marine segment provides construction and dredging services relating to marine transportation facility construction, marine pipeline construction, marine environmental structures, dredging of waterways, channels and ports, environmental dredging, design, and specialty services. The concrete segment generates maximum revenue and provides construction services for commercial, industrial, multi-family residential, and public projects, including the data center market.
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.